{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T05:10:54Z","timestamp":1793077854588,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"20","license":[{"start":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T00:00:00Z","timestamp":1700438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T00:00:00Z","timestamp":1700438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Qian Jiao He KY","award":["[2017]038"],"award-info":[{"award-number":["[2017]038"]}]},{"name":"Qian Ke He Ji","award":["[2017]1148"],"award-info":[{"award-number":["[2017]1148"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s00432-023-05497-1","type":"journal-article","created":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T13:02:37Z","timestamp":1700485357000},"page":"18081-18091","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A prospective phase II randomized study of docetaxel combined with lobaplatin versus TPF regimen induction chemotherapy followed by concurrent chemoradiotherapy for locally advanced head and neck squamous cell carcinoma"],"prefix":"10.1007","volume":"149","clinical-trial-number":[{"clinical-trial-number":"nct03117257","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Mang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weili","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhua","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuling","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuyun","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,20]]},"reference":[{"key":"5497_CR1","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1200\/JCO.2012.47.7802","volume":"31","author":"P Blanchard","year":"2013","unstructured":"Blanchard P, Bourhis J, Lacas B, Posner MR, Vermorken JB, Cruz Hernandez JJ et al (2013) Taxane-cisplatin-fluorouracil as induction chemotherapy in locally advanced head and neck cancers: an individual patient data meta-analysis of the meta-analysis of chemotherapy in head and neck cancer group. J Clin Oncol 31:2854\u20132860","journal-title":"J Clin Oncol"},{"key":"5497_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/annonc\/mdw376.02","volume":"27","author":"P Blanchard","year":"2016","unstructured":"Blanchard P, Landais C, Petit C et al (2016) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 100 randomized trials and 19,248 patients, on behalf of MACH-NC group. Ann Oncol 27:1","journal-title":"Ann Oncol"},{"key":"5497_CR17","doi-asserted-by":"publisher","unstructured":"Chen Y, Ismaila N, Chua M et al (2021) Chemotherapy in combination with radiotherapy for definitive-intent treatment of stage II-IVA nasopharyngeal carcinoma: CSCO and ASCO guideline[J].J Clin Oncol. https:\/\/doi.org\/10.1200\/JCO.20.03237","DOI":"10.1200\/JCO.20.03237"},{"issue":"25","key":"5497_CR3","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1200\/JCO.2013.54.6309","volume":"32","author":"Ezra E.W. Cohen","year":"2014","unstructured":"Cohen Ezra E.W., Karrison Theodore G, Kocherginsky Masha, Mueller Jeffrey, Egan Robyn, Huang Chao H, Brockstein Bruce E, Agulnik Mark B, Mittal Bharat B, Yunus Furhan, Samant Sandeep, Raez Luis E, Mehra Ranee, Kumar Priya, Ondrey Frank, Marchand Patrice, Braegas Bettina, Seiwert Tanguy Y, Villaflor Victoria M, Haraf Daniel J, Vokes Everett E (2014) Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer. J Clin Oncol Off J Am Soc Clin Oncol 32(25):2735\u201343","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"5497_CR4","doi-asserted-by":"publisher","first-page":"413","DOI":"10.7314\/APJCP.2013.14.1.413","volume":"14","author":"QQ Deng","year":"2013","unstructured":"Deng QQ, Huang XE, Ye LH, Lu YY, Liang Y, Xiang J (2013) Phase II trial of Loubo\u00ae (Lobaplatin) and pemetrexed for patients with metastatic breast cancer not responding to anthracycline or taxanes. Asian Pac J Cancer Prev 14:413\u2013417","journal-title":"Asian Pac J Cancer Prev"},{"key":"5497_CR5","first-page":"602","volume":"33","author":"T Hao","year":"2013","unstructured":"Hao T, Yesong G, Jiang M et al (2013) Radiosensitization of lobaplatin on human nasopharyngeal cancer cell line CNE2 in vitro. Chinese J Radiol Med Prot 33:602\u2013606","journal-title":"Chinese J Radiol Med Prot"},{"key":"5497_CR6","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1093\/annonc\/mdt461","volume":"25","author":"R Hitt","year":"2014","unstructured":"Hitt R, Grau JJ, L\u00f3pez-Pousa A, Berrocal A, Garc\u00eda-Gir\u00f3n C, Irigoyen A et al (2014) A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer. Ann Oncol 25:216\u2013225","journal-title":"Ann Oncol"},{"key":"5497_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejca.2021.03.051","volume":"151","author":"FelixHartl Keil","year":"2021","unstructured":"Keil FelixHartl, Altorjai Maximilian et al (2021) Docetaxel cisplatin and 5-FU compared with docetaxel cisplatin and cetuximab as induction chemotherapy in advanced squamous cell carcinoma of the head and neck: Results of a randomised phase II AGMT trial. Eur J Cancer: Off J Eur Org Res Treat Cancer (EORTC) Eur Assoc Cancer Res (EACR) 151:1","journal-title":"Eur J Cancer: Off J Eur Org Res Treat Cancer (EORTC) Eur Assoc Cancer Res (EACR)"},{"key":"5497_CR8","first-page":"125","volume":"26","author":"H Lu","year":"2019","unstructured":"Lu H, Daying M (2019) Clinical effect of docetaxel combined with lobaplatin in the treatment of cervical cancer. Chinese J Cancer Prev Treat 26:125\u2013126","journal-title":"Chinese J Cancer Prev Treat"},{"issue":"22","key":"5497_CR9","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1200\/JCO.2008.19.9109","volume":"27","author":"N Lee","year":"2009","unstructured":"Lee N, Harris J, Garden AS, Straube W, Glisson B, Xia P, Bosch W, Morrison WH, Quivey J, Thorstad W, Jones C, Ang KK (2009) Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225. J Clin Oncol. 27(22):3684\u201390","journal-title":"J Clin Oncol."},{"key":"5497_CR10","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1093\/jnci\/djq258","volume":"102","author":"AW Lee","year":"2010","unstructured":"Lee AW, Tung SY, Chua DT, Ngan RK, Chappell R, Tung R et al (2010) Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma. J Natl Cancer Inst 102:1188\u20131198","journal-title":"J Natl Cancer Inst"},{"key":"5497_CR11","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1186\/s12885-020-07297-z","volume":"20","author":"YG Lee","year":"2020","unstructured":"Lee YG, Kang EJ, Keam B, Choi JH, Kim JS, Park KU et al (2020) Treatment strategy and outcomes in locally advanced head and neck squamous cell carcinoma: a nationwide retrospective cohort study (KCSG HN13-01). BMC Cancer 20:813","journal-title":"BMC Cancer"},{"key":"5497_CR12","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/hed.23891","volume":"38","author":"CY Ock","year":"2016","unstructured":"Ock CY, Keam B, Lim Y, Kim TM, Lee SH, Kwon SK et al (2016) Effect of induction chemotherapy on survival in locally advanced head and neck squamous cell carcinoma treated with concurrent chemoradiotherapy: Single center experience. Head Neck 38:277\u2013284","journal-title":"Head Neck"},{"key":"5497_CR14","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3322\/caac.21601","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Goding Sauer A, Fedewa SA, Butterly LF, Anderson JC et al (2020) Colorectal cancer statistics, 2020. CA Cancer J Clin 70:145\u2013164","journal-title":"CA Cancer J Clin"},{"key":"5497_CR15","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s00066-015-0829-z","volume":"191","author":"Z Tak\u00e1csi-Nagy","year":"2015","unstructured":"Tak\u00e1csi-Nagy Z, Hitre E, Remen\u00e1r \u00c9, Oberna F, Polg\u00e1r C, Major T et al (2015) Docetaxel, cisplatin and 5-fluorouracil induction chemotherapy followed by chemoradiotherapy or chemoradiotherapy alone in stage III-IV unresectable head and neck cancer: Results of a randomized phase II study. Strahlenther Onkol 191:635\u2013641","journal-title":"Strahlenther Onkol"},{"key":"5497_CR16","doi-asserted-by":"publisher","first-page":"e18555","DOI":"10.1200\/JCO.2020.38.15_suppl.e18555","volume":"38","author":"Kannan Thanikachalam","year":"2020","unstructured":"Thanikachalam K, Krishnan J, Siddiqui F, Ali Haythem Y, Sheqwara J (2020) Carboplatin versus cetuximab chemoradiation in cisplatin ineligible locally advanced head and neck squamous cell carcinoma. J Clin Oncol 38:e18555\u2013e18555","journal-title":"J Clin Oncol"},{"key":"5497_CR18","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1158\/1078-0432.CCR-18-2244","volume":"25","author":"MR Trendowski","year":"2019","unstructured":"Trendowski MR, El Charif O, Dinh PC Jr, Travis LB, Dolan ME (2019) Genetic and Modifiable Risk Factors Contributing to Cisplatin-induced Toxicities. Clin Cancer Res 25:1147\u20131155","journal-title":"Clin Cancer Res"},{"key":"5497_CR19","doi-asserted-by":"publisher","first-page":"e157","DOI":"10.3747\/co.24.3489","volume":"24","author":"E Winquist","year":"2017","unstructured":"Winquist E, Agbassi C, Meyers BM, Yoo J, Chan KKW (2017) Systemic therapy in the curative treatment of head-and-neck squamous cell cancer: Cancer Care Ontario clinical practice guideline. Curr Oncol 24:e157\u2013e162","journal-title":"Curr Oncol"},{"key":"5497_CR21","first-page":"479","volume":"40","author":"X Yanqun","year":"2013","unstructured":"Yanqun X, Weixiong X, Sun X et al (2013) Inhibitory effect of lobaplatin on proliferation of head and neck squamous cell carcinoma cell lines in vitro. J Int Oncol 40:479-480","journal-title":"J Int Oncol"},{"issue":"10","key":"5497_CR20","first-page":"937","volume":"20","author":"H Yong","year":"2015","unstructured":"Yong H, Shukui Q (2015) Experimental and clinical research current situation and progress of lobaplatin in the treatment of nonsmall cell lung cancer[J].Chinese Clin Oncol 20(10):937\u2013941","journal-title":"Chinese Clin Oncol"},{"key":"5497_CR13","unstructured":"Yu P, Jiang K et al (2014) Clinical progression of lobaplatin in combination chemotherapy for patients with recurrence or metastatic cancer. Chinese-German J Clin Oncol (English Edition) 000:386\u2013391"},{"key":"5497_CR22","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.bone.2016.02.005","volume":"21","author":"S Zhang","year":"2016","unstructured":"Zhang S, Lin S, Hu L (2016) Lobaplatin combined with docetaxel neoadjuvant chemotherapy followed by concurrent lobaplatin with intensity-modulated radiotherapy increases the survival of patients with high-risk lymph node positive nasopharyngeal carcinoma. J Buon 21:161\u2013167","journal-title":"J Buon"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-023-05497-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-023-05497-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-023-05497-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T10:06:39Z","timestamp":1702721199000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-023-05497-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,20]]},"references-count":22,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["5497"],"URL":"https:\/\/doi.org\/10.1007\/s00432-023-05497-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3239167\/v1","asserted-by":"object"}]},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,20]]},"assertion":[{"value":"6 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. This study has been performed in accordance with the Declaration of Helsinki and has been approved by the Ethics Committee, the approval number is 2017-01, and all patients signed informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}